Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Jointown Pharmaceutical Group Co's PEG Ratio or its related term are showing as below:
SHSE:600998'
s PEG Ratio Range Over the Past 10 Years
Min: 0.45 Med: 1.12 Max: 58.25
Current: 57.9
During the past 13 years, Jointown Pharmaceutical Group Co's highest PEG Ratio was 58.25. The lowest was 0.45. And the median was 1.12.
SHSE:600998's PEG Ratio is ranked worse than 93.88% of 49
companies
in the Medical Distribution industry
Industry Median: 1.96
vs SHSE:600998: 57.90
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Jointown Pharmaceutical Group Co (SHSE:600998) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Jointown Pharmaceutical Group Co PEG Ratio Related Terms
Jointown Pharmaceutical Group Co PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600998 vs MCK, COR, CAH: PEG Ratio Comparison
For the Medical Distribution subindustry, Jointown Pharmaceutical Group Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jointown Pharmaceutical Group Co PEG Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Jointown Pharmaceutical Group Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Jointown Pharmaceutical Group Co's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Jointown Pharmaceutical Group Co (SHSE:600998) has a PEG Ratio of 57.92 as of Jul. 29, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Jointown Pharmaceutical Group Co and its competitors. This is 5071% above median its historical median of 1.12. Over the past decade, Jointown Pharmaceutical Group Co's PEG Ratio has ranged from 0.45 to 58.25. According to the industry distribution chart, Jointown Pharmaceutical Group Co ranks #46 out of 49 companies in the Medical Distribution industry, placing it in the top 93.9%.
Is Jointown Pharmaceutical Group Co's PEG Ratio too high?
Jointown Pharmaceutical Group Co's current PEG Ratio of 57.92 is 5071% above median its 10-year median of 1.12. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 58.25. The Medical Distribution industry median PEG Ratio is 1.96. Jointown Pharmaceutical Group Co's value of 57.92 is 2855.1% above this industry median. Based on the distribution chart, Jointown Pharmaceutical Group Co ranks #46 out of 49 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Jointown Pharmaceutical Group Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jointown Pharmaceutical Group Co's PEG Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Jointown Pharmaceutical Group Co ranks #46 out of 49 companies for PEG Ratio. This places Jointown Pharmaceutical Group Co in the lower half of its industry. The industry median PEG Ratio is 1.96. Jointown Pharmaceutical Group Co's value of 57.92 is 2855.1% above this benchmark. Historically, Jointown Pharmaceutical Group Co's own PEG Ratio has ranged from 0.45 to 58.25 over the past decade. While the company's 10-year median is 1.12 vs. the industry median of 1.96, Jointown Pharmaceutical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Distribution company?
The median PEG Ratio among Medical Distribution companies is 1.96, based on 49 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jointown Pharmaceutical Group Co's current PEG Ratio of 57.92 is 2855.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Jointown Pharmaceutical Group Co and its competitors. For the Medical Distribution industry, the median PEG Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jointown Pharmaceutical Group Co's current PEG Ratio is 57.92, which is 5071% above median its own 10-year median of 1.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jointown Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Jointown Pharmaceutical Group Co (SHSE:600998) is currently considered Fairly Valued. The stock's GF Value™ is ¥5.58, compared to a current price of ¥5.12 — trading 8.2% below its estimated fair value. The current PEG Ratio is 57.92, which is 5071% above median its 10-year median of 1.12 and 2855.1% above the Medical Distribution industry median of 1.96. Jointown Pharmaceutical Group Co's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Jointown Pharmaceutical Group Co (SHSE:600998), the current PEG Ratio is 57.92 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jointown Pharmaceutical Group Co (SHSE:600998) Overvalued in 2026?
Based on GuruFocus' analysis, Jointown Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of ¥5.12 is trading 8.2% below its estimated GF Value™ of ¥5.58.
GuruFocus considers Jointown Pharmaceutical Group Co to be Fairly Valued.
Key valuation signals for SHSE:600998:
PEG Ratio: 57.92 (5071% above median its 10-year median of 1.12)
GF Value™: ¥5.58 vs. price of ¥5.12 (8.2% below fair value)
Industry Position: 2855.1% above the Medical Distribution median (#46 of 49)
No single metric tells the full story. See the SHSE:600998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jointown Pharmaceutical Group Co Business Description
Jointown Pharmaceutical Group Co Ltd is engaged in the business of wholesaling drugs and medical devices. The company offers logistics and other value-added services and mainly serves medical institutions, wholesale enterprises, and retail pharmacies.
81GF Score
Get the complete analysis for SHSE:600998
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600998 has been successfully added to your 
